Revance Therapeutics (RVNC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist

3.730
+0.120+3.32%

Close Dec 2 16:00 ET

3.840
+0.110+2.95%

Post 19:53 ET

391.29MMarket Cap-1942P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Revance Therapeutics Extends Tender Offer Deadline For Merger With Crown Laboratories To December 3, 2024 Amid Ongoing Discussions
BenzingaNov 29 06:25 ET
Express News | Revance Therapeutics Inc - Ongoing Discussions May Result in Further Delays or Modifications to Merger Agreement
ReutersNov 29 06:07 ET
Barclays Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Maintains Target Price $7
Moomoo NewsNov 18 04:32 ET · Ratings
Barclays Remains a Hold on Revance Therapeutics (RVNC)
TipRanksNov 18 04:07 ET · Ratings
Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating
Moomoo NewsNov 13 03:31 ET · Ratings
Cautious Hold Rating on Revance Therapeutics Amid Ongoing Merger Uncertainties With Crown Laboratories
TipRanksNov 13 02:45 ET · Ratings

Comments

$Revance Therapeutics (RVNC.US)$ It is a bullish sign as the extension only has 4 days. It has a deal

4

$Revance Therapeutics (RVNC.US)$ when the deal is over this should start with 6,60 easy

1

$Revance Therapeutics (RVNC.US)$ The deal is going forward . It is free for $0.7 per share. Bought more

$Revance Therapeutics (RVNC.US)$ its not moving at all from 5,90 or iam imagining

Unusual Volume Ticks. 11:07am 10/28

$Fractyl Health (GUTS.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$ $Oklo Inc (OKLO.US)$ $Revance Therapeutics (RVNC.US)$ $PROCEPT BioRobotics (PRCT.US)$ $Atlas Lithium (ATLX.US)$ $EyePoint Pharmaceuticals (EYPT.US)$ $Porch Group (PRCH.US)$ $Top Wealth Group Holding (TWG.US)$ $Global Mofy AI (GMM.US)$ $Monte Rosa Therapeutics (GLUE.US)$ $Evoke Pharma (EVOK.US)$ $Greenlane (GNLN.US)$ $Autonomix Medical (AMIX.US)$ $Healthcare Triangle (HCTI.US)$
📊⚡️📊

Unusual Volume Ticks. 11:07am 10/28

10

6

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data